ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis

NCT02510599 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis

NCT03193502 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.

NCT06293378 ·Status: RECRUITING ·Phase: NA

Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver

NCT02273362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients

NCT05621005 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

NCT05117489 ·Status: COMPLETED ·Phase: PHASE1

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NCT05039450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

NCT04767529 ·Status: COMPLETED ·Phase: PHASE2

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study

NCT05663944 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

NCT05461105 ·Status: COMPLETED ·Phase: PHASE2

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

NCT05979779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

NCT00582738 ·Status: TERMINATED ·Phase: PHASE2

Effect of Some Drugs on Liver Fibrosis

NCT03770936 ·Status: RECRUITING ·Phase: PHASE3

A Study of IDN-6556 in Subjects With Liver Cirrhosis

NCT02230670 ·Status: COMPLETED ·Phase: PHASE2

A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

NCT00562783 ·Status: COMPLETED ·Phase: PHASE2

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

NCT05370053 ·Status: COMPLETED ·Phase: NA

Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure

NCT01037959 ·Status: TERMINATED ·Phase: PHASE3

Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.

NCT03721627 ·Status: UNKNOWN ·Phase: PHASE4

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT06528314 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment

NCT03713242 ·Status: COMPLETED ·Phase: PHASE1

Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554

NCT00651027 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379

NCT04208399 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis

NCT00973817 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

NCT04835480 ·Status: RECRUITING ·Phase: PHASE2

A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

NCT05917938 ·Status: COMPLETED ·Phase: PHASE1